Skip to main content
x

News & Events

We need your help.

The Oxalosis & Hyperoxaluria Foundation is dedicated to the awareness, understanding, and treatment of primary hyperoxaluria, oxalosis, and related hyperoxaluria kidney stone conditions. Our news and events page is designed to help you stay up to date on the latest research breakthroughs, important events, and personal stories that affect the oxalosis and hyperoxaluria community.

Upcoming Events

Latest News

FDA Grants Priority Review to Alnylam&#39;s RNAi Therapy for Primary <b>Hyperoxaluria</b> Type 1
At the time, Kim Hollander, executive director of the Oxalosis and Hyperoxaluria Foundation, said, “The ILLUMINATE-A results represents a significant ...
Read More
FDA Grants Priority Review to Alnylam&#39;s RNAi Therapy for Primary <b>Hyperoxaluria</b> Type 1
At the time, Kim Hollander, executive director of the Oxalosis and Hyperoxaluria Foundation, said, “The ILLUMINATE-A results represents a significant ...
Read More
FDA Grants Priority Review to Alnylam&#39;s RNAi Therapy for Primary <b>Hyperoxaluria</b> Type 1
At the time, Kim Hollander, executive director of the Oxalosis and Hyperoxaluria Foundation, said, “The ILLUMINATE-A results represents a significant ...
Read More
FDA Grants Priority Review to Alnylam&#39;s RNAi Therapy for Primary <b>Hyperoxaluria</b> Type 1
At the time, Kim Hollander, executive director of the Oxalosis and Hyperoxaluria Foundation, said, “The ILLUMINATE-A results represents a significant ...
Read More